Shortlisted
Regeneron Pharmaceuticals
REGNHealthcare · Biotechnology · US790.74USD-0.70%
StratDeckRegeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
Price · Past year
Loading chart…
Checks
- Pass: Price trending up The figures
- Pass: Sales growing faster than its peers The figures
- Pass: More profitable than similar companies The figures
- Pass: Analysts rate it a buy The figures
- Pass: Cheaper than similar companies The figures
- Pass: Beat profit forecasts The figures
Share
Keep researching
Where next from REGN
Other stocks you may like
Fundamentals
SEC EDGAR
Yahoo FinanceShowHide
What's happening?
REGN is lagging Healthcare this month The figures
- 1D
- -0.70%
- 7D
- +5.92%
- 1M
- +2.08%
- 3M
- +16.99%
- 6M
- +5.63%
- YTD
- +2.84%
What is the market expecting?
StratDeckCheaper than similar companies, and analysts expect the price to rise The figures
Value score vs Healthcare peers
59- Fwd P/E12.876
- P/B2.569
- Yield0.5%10
- P/E19.678
- Rev growth+16.7%94
Is the business delivering?
Sales are growing faster than at similar companies, and profit per share is down The figures
Earnings by quarter
Latest quarter 1.30B · +570M on the quarter before · -94.7M on a year earlier
- 1.34BOct24-91.7M
- 918MFeb25-423M
- 809MApr25-109M
- 1.39BAug25+583M
- 1.46BOct25+68.4M
- 845MJan26-615M
- 727MApr26-117M
- 1.30BJul26+570M
How does it compare?
Nearest in Healthcare on valueStratDeckREGN is better value than most Healthcare stocks The figures
What happens next?
Reports next on 30 Oct, in 13 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.